Abubakar, I., Cobelens, F. G. J., & Rangaka, M. X. (2019). The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials. Am J Respir Crit Care Med.
Chicago Style CitationAbubakar, Ibrahim, Frank G. J. Cobelens, and Molebogeng X. Rangaka. "The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials." Am J Respir Crit Care Med 2019.
MLA CitationAbubakar, Ibrahim, Frank G. J. Cobelens, and Molebogeng X. Rangaka. "The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials." Am J Respir Crit Care Med 2019.
Warning: These citations may not always be 100% accurate.